US 9340782
Antimir-451 for the treatment of polycythemias
granted A61PA61P11/00A61P35/00
Quick answer
US patent 9340782 (Antimir-451 for the treatment of polycythemias) held by The Board of Regents of the University of Texas System expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P11/00, A61P35/00, A61P35/02, A61P43/00